<--- Back to Details
First PageDocument Content
Signal transduction / Pharmacology / Alcohols / Morphinans / Drug rehabilitation / Receptor antagonist / Dynorphin / Opioid receptor / Buprenorphine / Biology / Chemistry / Neurochemistry
Signal transduction
Pharmacology
Alcohols
Morphinans
Drug rehabilitation
Receptor antagonist
Dynorphin
Opioid receptor
Buprenorphine
Biology
Chemistry
Neurochemistry

Add to Reading List

Source URL: www.jbc.org

Download Document from Source Website

Share Document on Facebook

Similar Documents

PRODUCT MONOGRAPH  COZAAR® losartan potassium tablets 25, 50 and 100 mg Angiotensin II Receptor Antagonist

PRODUCT MONOGRAPH COZAAR® losartan potassium tablets 25, 50 and 100 mg Angiotensin II Receptor Antagonist

DocID: 1uB2r - View Document

Comments to the 2007 recommendations for the treatment of essential hypertension by the Swiss Society of Hypertension

Comments to the 2007 recommendations for the treatment of essential hypertension by the Swiss Society of Hypertension

DocID: 1r7aU - View Document

These opinions do not represent the opinions of WebMD zantac over the counter. If you are breast-feeding a baby. Sibutramine can be given to pets with or without food. Do not double the dose of zolpidem when ketoconazole

These opinions do not represent the opinions of WebMD zantac over the counter. If you are breast-feeding a baby. Sibutramine can be given to pets with or without food. Do not double the dose of zolpidem when ketoconazole

DocID: 1qTdT - View Document

lisinopril pregnancy class. lisinopril dosis letal, lisinopril vs altace hydrochloroth lisinopril. negative side effects of lisinopril. lisinopril zinc and selenium lisinopril tablets wockhardt, dangerous side affects of

lisinopril pregnancy class. lisinopril dosis letal, lisinopril vs altace hydrochloroth lisinopril. negative side effects of lisinopril. lisinopril zinc and selenium lisinopril tablets wockhardt, dangerous side affects of

DocID: 1qMap - View Document

Proceedings of the British Pharmacological Society at http://www.pA2online.org/abstracts/Vol7Issue4abst086P.pdf  Using the fluorescent antagonist, XAC-X-BY630 to quantify antagonist-adenosine A3 receptor complexes in mem

Proceedings of the British Pharmacological Society at http://www.pA2online.org/abstracts/Vol7Issue4abst086P.pdf Using the fluorescent antagonist, XAC-X-BY630 to quantify antagonist-adenosine A3 receptor complexes in mem

DocID: 1qBQB - View Document